DiaSorin Statistics
Total Valuation
DiaSorin has a market cap or net worth of GBP 4.62 billion. The enterprise value is 5.20 billion.
Market Cap | 4.62B |
Enterprise Value | 5.20B |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | May 20, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 21.12M |
Valuation Ratios
The trailing PE ratio is 29.42.
PE Ratio | 29.42 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.07, with an EV/FCF ratio of 19.15.
EV / Earnings | 33.07 |
EV / Sales | 5.27 |
EV / EBITDA | 17.07 |
EV / EBIT | 24.71 |
EV / FCF | 19.15 |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.43 |
Debt / EBITDA | 1.88 |
Debt / FCF | 2.10 |
Interest Coverage | 8.59 |
Financial Efficiency
Return on equity (ROE) is 11.85% and return on invested capital (ROIC) is 6.38%.
Return on Equity (ROE) | 11.85% |
Return on Assets (ROA) | 5.73% |
Return on Invested Capital (ROIC) | 6.38% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 305,528 |
Profits Per Employee | 48,971 |
Employee Count | 3,233 |
Asset Turnover | 0.43 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.04% in the last 52 weeks. The beta is 0.19, so DiaSorin's price volatility has been lower than the market average.
Beta (5Y) | 0.19 |
52-Week Price Change | +21.04% |
50-Day Moving Average | 103.09 |
200-Day Moving Average | 99.12 |
Relative Strength Index (RSI) | 51.85 |
Average Volume (20 Days) | 14,387 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DiaSorin had revenue of GBP 980.44 million and earned 157.15 million in profits. Earnings per share was 2.95.
Revenue | 980.44M |
Gross Profit | 642.57M |
Operating Income | 209.29M |
Pretax Income | 198.23M |
Net Income | 157.15M |
EBITDA | 293.71M |
EBIT | 209.29M |
Earnings Per Share (EPS) | 2.95 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 570.85M |
Net Cash | -570.85M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.34B |
Book Value Per Share | 25.13 |
Working Capital | 302.90M |
Cash Flow
In the last 12 months, operating cash flow was 309.28 million and capital expenditures -37.83 million, giving a free cash flow of 271.44 million.
Operating Cash Flow | 309.28M |
Capital Expenditures | -37.83M |
Free Cash Flow | 271.44M |
FCF Per Share | n/a |
Margins
Gross margin is 65.54%, with operating and profit margins of 21.35% and 16.03%.
Gross Margin | 65.54% |
Operating Margin | 21.35% |
Pretax Margin | 20.22% |
Profit Margin | 16.03% |
EBITDA Margin | 29.96% |
EBIT Margin | 21.35% |
FCF Margin | 27.69% |
Dividends & Yields
DiaSorin does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | 2.79% |
Years of Dividend Growth | 5 |
Payout Ratio | 31.22% |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 3.40% |
FCF Yield | 5.87% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |